The next board meeting for Monte Rosa Therapeutics Inc is on 20 Mar 2026 for the purpose of Monte Rosa Therapeutics Inc Fourth Quarter Earnings Results for 2025See details
Monte Rosa Therapeutics Inc - GLUE - stock price prediction, stock price target, analyst ratings from 8 analysts
Monte Rosa Therapeutics Inc has a share price target of US$ 33, revenue growth forecast of 80.5%, and profit growth estimate of 70.4% for FY25, based on top 8 analyst calls.